Home

PHILIP J HEMPLEMAN

CIK 1025710 · last filed 2021-11-15

PHILIP J HEMPLEMAN is a corporate insider who has filed 2 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing shows the insider exercised options on $3.2M of MBII on Nov 15, 2021. Across all open-market trades the lifetime net is −$5.9M, making them a net seller over the disclosed history. 56 SEC filings were submitted jointly with Ardsley Partners I GP LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

2

Lifetime Open-Market Net

-$5.93M

Filer Profile

Reported Address
262 HARBOR DRIVE, 4TH FLOOR
STAMFORD, CT 06902
Related Filers
Ardsley Partners I GP LLC — 56 joint filings, latest 2021-11-15
ARDSLEY ADVISORY PARTNERS LP — 54 joint filings, latest 2021-11-15
Ardsley Partners Renewable Energy Fund, L.P. — 54 joint filings, latest 2021-11-15
Ardsley Partners Fund II, L.P. — 42 joint filings, latest 2021-11-15
Ardsley Duckdive Fund, L.P. — 25 joint filings, latest 2021-01-04
Ardsley Advisory Partners GP LLC — 21 joint filings, latest 2021-11-15
Ardsley Partners Advanced Healthcare Fund, L.P. — 15 joint filings, latest 2021-11-15
Ardsley Healthcare Fund, L.P. — 11 joint filings, latest 2020-08-20
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MARRONE BIO INNOVATIONS INC (MBII) Delisted 18,335,767 $0.80 $14.63M $0 1 2021-11-15
SunOpta Inc. (STKL) Delisted 12,080,155 $6.50 $78.52M -$5.93M 1 2020-08-07

Recent Filings

2 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-11-15 MARRONE BIO INNOVATIONS INC (MBII) Delisted Exer (X) +4,326,098 $3.24M EDGAR
2020-08-07 SunOpta Inc. (STKL) Delisted Sell (S) −900,000 -$5.93M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.